WebJun 15, 2024 · Background: As a type of breast cancer that has relatively strong invasiveness, triple negative breast cancer (TNBC) seriously affects the survival of patients. microRNAs (miRNAs) have been shown to exert a prominent regulatory effect on the disease, among which miR-133b is reported to be involved in the pathological … WebRetrieving IC50 drug data... The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger …
Effect of bortezomib in combination with cisplatin and 5 ... - PubMed
WebFeb 28, 2024 · All the new complexes showed cytotoxicity in vitro against the three cancer cell lines, but only complex 1a showed statistically significant different activity compared with cisplatin, with significantly lower IC 50 values, 4.31, 6.23, and 4.80 μM, compared with 9.71, 14.48, and 11.59 μM for cisplatin against A549, SKOV3, and MCF-7, respectively. WebApr 12, 2024 · Taking NVP-BEZ235 (BEZ235) as an example to screen drug response-related genes (DRRGs) and explore their potential value in triple-negative breast cancer (TNBC). Through high-throughput technique ... small pools to buy
Cisplatin in combination with programmed cell death protein 5 …
WebWhat Cisplatin Is Used For: Treatment of advanced bladder cancer, metastatic ovarian cancer, and metastatic testicular cancer. Testicular, ovarian, bladder, head and neck, esophageal, small and non-small cell lung, breast, cervical, stomach and prostate cancers. WebJan 26, 2015 · The IC 50 values were 114.1 and 50.6 μ M in Du145 and PC3 cells, respectively, indicating the synergistic effects of transfection of Pdcd5 and cisplatin treatment. Figure 3 Cell viability of Du145 and PC3 prostate cancer cells following transfection of Pdcd5. WebTriple-negative breast cancer (TNBC) is a highly aggressive type of breast cancer lacking estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth … highlights italia belgio femminile